Weighing the Impact of Iran's Uranium Program

{
  "authors": [
    "Pierre Goldschmidt"
  ],
  "type": "legacyinthemedia",
  "centerAffiliationAll": "dc",
  "centers": [
    "Carnegie Endowment for International Peace"
  ],
  "collections": [],
  "englishNewsletterAll": "",
  "nonEnglishNewsletterAll": "",
  "primaryCenter": "Carnegie Endowment for International Peace",
  "programAffiliation": "NPP",
  "programs": [
    "Nuclear Policy"
  ],
  "projects": [],
  "regions": [
    "Middle East",
    "Iran"
  ],
  "topics": []
}

In The Media

Weighing the Impact of Iran's Uranium Program

By Pierre Goldschmidt

Published on Dec 11, 2007

Source: NPR's Morning Edition

The unclassified National Intelligence Estimate (NIE) on Iran, released December 3, reported that Iran ended efforts to build a nuclear weapon in 2003. Yet even if Iran has, in fact, stopped these efforts, it continues to pursue uranium enrichment and other technical capabilities that could be applied to producing nuclear weapons.

The NIE did not draw a clear distinction between the intention to develop nuclear weapons and the intention to develop a nuclear weapons capability, Carnegie's Pierre Goldschmidt says.

Click here to listen to the broadcast.

About the Author

Pierre Goldschmidt

Former Nonresident Senior Associate, Nuclear Policy Program

Goldschmidt was a nonresident senior associate at the Carnegie Endowment.

Recent Work

Article
A Realistic Approach Toward a Middle East Free of WMD
- Pierre Goldschmidt
Article
Serious Deficiencies Exposed by Latest IAEA Safeguards Implementation Report
- Pierre Goldschmidt

Middle East Iran

Carnegie India does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.

More Work from Carnegie India

Article
Risk and Retaliation: Israel, Iran, and the Evolving Situation in West Asia
An Israeli response to Iran’s October 1 attack is imminent. The key question is of its intensity and potential fallout, both within Iran, in terms of nuclear security policy changes, and across the broader region. The coming days are likely to reshape West Asia irreversibly.
Gaddam Dharmendra
Commentary
How WHO’s “One Health” Program Can Help India Tackle Monkeypox
With monkeypox being declared a global health emergency, the WHO approach is an innovative and effective way to curb outbreaks of zoonotic diseases.
Shruti Sharma
Paper
Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in India
In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.
Shruti Sharma
Commentary
Combating Vaccine Hesitancy in India
Unless the government can up its communications game, anti-vax movements could prolong India’s pandemic effects.
Shruti Sharma
Commentary
How Should Countries Study Viruses Safely?
The uncertain origin of the coronavirus has focused attention on gain-of-function research—studying viruses to learn how they spread. How can countries work together to ensure stringent safety standards?
Shruti Sharma

More Work from Carnegie India

Article

Risk and Retaliation: Israel, Iran, and the Evolving Situation in West Asia

An Israeli response to Iran’s October 1 attack is imminent. The key question is of its intensity and potential fallout, both within Iran, in terms of nuclear security policy changes, and across the broader region. The coming days are likely to reshape West Asia irreversibly.

Gaddam Dharmendra

Commentary

How WHO’s “One Health” Program Can Help India Tackle Monkeypox

With monkeypox being declared a global health emergency, the WHO approach is an innovative and effective way to curb outbreaks of zoonotic diseases.

Shruti Sharma

Paper

Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in India

In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.

Shruti Sharma

Commentary

Combating Vaccine Hesitancy in India

Unless the government can up its communications game, anti-vax movements could prolong India’s pandemic effects.

Shruti Sharma

Commentary

How Should Countries Study Viruses Safely?

The uncertain origin of the coronavirus has focused attention on gain-of-function research—studying viruses to learn how they spread. How can countries work together to ensure stringent safety standards?

Shruti Sharma